.png){kind=icon}
返回
Wilson disease
.png){kind=icon}
OA
AI
DOI：10.1038/s41572-018-0018-3.png)
.png){kind=icon}
.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Wilson disease (WD) is a potentially treatable, inherited disorder of copper metabolism that is characterized by the pathological accumulation of copper. WD is caused by mutations in ATP7B, which encodes a transmembrane copper-transporting ATPase, leading to impaired copper homeostasis and copper overload in the liver, brain and other organs. The clinical course of WD can vary in the type and severity of symptoms, but progressive liver disease is a common feature. Patients can also present with neurological disorders and psychiatric symptoms. WD is diagnosed using diagnostic algorithms that incorporate clinical symptoms and signs, measures of copper metabolism and DNA analysis of ATP7B. Available treatments include chelation therapy and zinc salts, which reverse copper overload by different mechanisms. Additionally, liver transplantation is indicated in selected cases. New agents, such as tetrathiomolybdate salts, are currently being investigated in clinical trials, and genetic therapies are being tested in animal models. With early diagnosis and treatment, the prognosis is good; however, an important issue is diagnosing patients before the onset of serious symptoms. Advances in screening for WD may therefore bring earlier diagnosis and improvements for patients with WD.
Keyword:
OPTICAL COHERENCE TOMOGRAPHY
COPPER TRANSPORTER ATP7B
TOXICOSIS GENE MURR1
QUALITY-OF-LIFE
GLOBAL DNA METHYLATION
LIVER-TRANSPLANTATION
NEUROLOGICAL MANIFESTATIONS
PSYCHIATRIC MANIFESTATIONS
METHIONINE METABOLISM
CLINICAL PRESENTATION
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
N
IF:
60.6
论文数:
649
被引数:
3.8W
机构
引用论文
The impact of apolipoprotein E genotypes on age at onset of symptoms and phenotypic expression in Wilson's disease.png)
BRAINOAAI
BRAINIF11.7
OAAI分享收藏
分享收藏
查看更多内容